Aprea Therapeutics, Inc. ( APRE) - Stock Earnings
APRE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
APRE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.5 million USD | 3337 USD |
| 2026Q1 | -3.3 million USD | — USD |
| 2026Q2 | -3.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
APRE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.3 million USD | 583231 USD |
| 2024 | -13.0 million USD | 1.5 million USD |
| 2025 | -12.6 million USD | 285759 USD |
| 2026 Est. | — | — |
APRE
Price: $0.60
52 week price:
Earnings Per Share: -1.49 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 118567
Market Capitalization: 8.6 million